ロード中...
Essential thrombocythemia treatment algorithm 2018
Current drug therapy for myeloproliferative neoplasms, including essential thrombocythemia (ET) and polycythemia vera (PV), is neither curative nor has it been shown to prolong survival. Fortunately, prognosis in ET and PV is relatively good, with median survivals in younger patients estimated at 33...
保存先:
| 出版年: | Blood Cancer J |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802626/ https://ncbi.nlm.nih.gov/pubmed/29321520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0041-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|